TFF Pharmaceuticals Inc (TFFP)
0.3761
-1.22
(-76.49%)
USD |
NASDAQ |
Nov 15, 16:00
0.3651
-0.01
(-2.92%)
After-Hours: 20:00
TFF Pharmaceuticals Revenue (Quarterly): 0.6502M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.6502M |
| March 31, 2024 | 0.2033M |
| December 31, 2023 |
| Date | Value |
|---|---|
| September 30, 2023 | |
| June 30, 2023 | 0.3334M |
| March 31, 2023 | 0.0514M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0514M
Minimum
Mar 2023
0.6502M
Maximum
Jun 2024
0.3096M
Average
0.2683M
Median
Revenue (Quarterly) Benchmarks
| Eyenovia Inc | 0.0226M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | 0.35M |
| iBio Inc | 0.175M |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.479M |
| Total Expenses (Quarterly) | 4.613M |
| EPS Diluted (Quarterly) | -1.22 |
| Enterprise Value | -3.084M |
| Profit Margin (Quarterly) | -688.9% |
| Earnings Yield | -1.99K% |
| Normalized Earnings Yield | -1945.54 |